ACS-话题@MedSci

#ACS#

406篇内容 | 2765人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1279367, encodeId=6c6912e93670c, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=Circulation：肌钙蛋白筛查ACS时，长期结果显示0/1小时策略不劣于0/3标准方案（RAPID-TnT研究）, objectType=article, longId=214812, objectId=e715214812fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e715214812fa, replyNumber=0, likeNumber=43, createdTime=2021-07-27, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e715214812fa, moduleTitle=Circulation：肌钙蛋白筛查ACS时，长期结果显示0/1小时策略不劣于0/3标准方案（RAPID-TnT研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e715214812fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279365, encodeId=a32d12e9365fd, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=Cardiovasc Diabetol：胰岛素治疗显著增加合并ACS的T2D患者的MACE复发风险！, objectType=article, longId=213452, objectId=4a9121345224, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a9121345224, replyNumber=0, likeNumber=29, createdTime=2021-06-30, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a9121345224, moduleTitle=Cardiovasc Diabetol：胰岛素治疗显著增加合并ACS的T2D患者的MACE复发风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a9121345224)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279364, encodeId=6d5f12e9364bb, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=J Med Chem: 双PROTAC来了：我国学者首次提出双重靶向降解（Dual PROTACs）药物设计新概念, objectType=article, longId=212128, objectId=c3ae212128cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3ae212128cd, replyNumber=0, likeNumber=48, createdTime=2021-06-02, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3ae212128cd, moduleTitle=J Med Chem: 双PROTAC来了：我国学者首次提出双重靶向降解（Dual PROTACs）药物设计新概念, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3ae212128cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279363, encodeId=7e2612e936314, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=ACS Biomater. Sci. Eng.：创新伤口新辅料，或将改善抗生素预防感染新格局, objectType=article, longId=211201, objectId=fb6721120108, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb6721120108, replyNumber=0, likeNumber=35, createdTime=2021-05-14, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb6721120108, moduleTitle=ACS Biomater. Sci. Eng.：创新伤口新辅料，或将改善抗生素预防感染新格局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb6721120108)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279362, encodeId=22a012e936224, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=EHRA 2021｜《2021 EHRA 房颤患者NOACs应用实践指南》重磅发布！, objectType=article, longId=210559, objectId=4e612105596b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e612105596b, replyNumber=0, likeNumber=36, createdTime=2021-04-29, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e612105596b, moduleTitle=EHRA 2021｜《2021 EHRA 房颤患者NOACs应用实践指南》重磅发布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e612105596b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279361, encodeId=61d312e93611c, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=全病程、多方位，数字化：“胸痛中心全流程管理——ACS脂控先锋”项目正式启动, objectType=article, longId=209992, objectId=a0fd209992e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0fd209992e0, replyNumber=0, likeNumber=45, createdTime=2021-04-16, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0fd209992e0, moduleTitle=全病程、多方位，数字化：“胸痛中心全流程管理——ACS脂控先锋”项目正式启动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0fd209992e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279366, encodeId=320212e93663f, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=轻松构建“智惠版”先进细胞分析平台！碧迪医疗正式发布FACSymphony TM A1流式细胞仪, objectType=article, longId=209844, objectId=33b620984435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33b620984435, replyNumber=0, likeNumber=34, createdTime=2021-04-13, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33b620984435, moduleTitle=轻松构建“智惠版”先进细胞分析平台！碧迪医疗正式发布FACSymphony TM A1流式细胞仪, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33b620984435)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279360, encodeId=b07212e93600b, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=综述：靶向蛋白降解(PROTACs)癌症治疗药物机制、以及新近进展、国内相关研发公司, objectType=article, longId=209142, objectId=df2420914253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2420914253, replyNumber=0, likeNumber=35, createdTime=2021-03-30, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2420914253, moduleTitle=综述：靶向蛋白降解(PROTACs)癌症治疗药物机制、以及新近进展、国内相关研发公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2420914253)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279359, encodeId=701812e9359c4, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=JACC：采用双重抗血小板治疗的ACS患者或许不需停用氯吡格雷5天后才能进行冠脉搭桥术, objectType=article, longId=208463, objectId=572b208463ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=572b208463ff, replyNumber=0, likeNumber=37, createdTime=2021-03-17, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=572b208463ff, moduleTitle=JACC：采用双重抗血小板治疗的ACS患者或许不需停用氯吡格雷5天后才能进行冠脉搭桥术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=572b208463ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279358, encodeId=79e512e935864, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=J Am Coll Cardiol：大多ACS住院患者存在无明显出血的血红蛋白降低，且与一年死亡率相关, objectType=article, longId=207924, objectId=6cc520e924be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cc520e924be, replyNumber=0, likeNumber=35, createdTime=2021-03-07, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cc520e924be, moduleTitle=J Am Coll Cardiol：大多ACS住院患者存在无明显出血的血红蛋白降低，且与一年死亡率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cc520e924be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279357, encodeId=e3be12e9357d5, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=ACS Nano ：“撒泡尿照照”！AI诊断前列腺癌全新突破，只需20分钟，准确性近100%, objectType=article, longId=206533, objectId=d9a82065336b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9a82065336b, replyNumber=0, likeNumber=37, createdTime=2021-02-02, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9a82065336b, moduleTitle=ACS Nano ：“撒泡尿照照”！AI诊断前列腺癌全新突破，只需20分钟，准确性近100%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9a82065336b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279356, encodeId=00aa12e9356b1, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=急性冠脉综合征ACS合并上消化道出血的诊治, objectType=article, longId=203984, objectId=b75620398469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b75620398469, replyNumber=0, likeNumber=43, createdTime=2020-12-02, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b75620398469, moduleTitle=急性冠脉综合征ACS合并上消化道出血的诊治, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b75620398469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279355, encodeId=12c512e93555a, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=ACS Nano：复旦占昌友团队揭示天然IgG吸附，导致叶酸修饰纳米药物的失效, objectType=article, longId=203410, objectId=d97820341047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d97820341047, replyNumber=0, likeNumber=1004, createdTime=2020-11-16, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d97820341047, moduleTitle=ACS Nano：复旦占昌友团队揭示天然IgG吸附，导致叶酸修饰纳米药物的失效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d97820341047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279354, encodeId=5ec812e935475, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=EuroIntervention：接受COMBO支架治疗的ACS患者，3个月vs12个月的DAPT结局——REDUCE试验结果, objectType=article, longId=203297, objectId=cfda20329e51, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfda20329e51, replyNumber=0, likeNumber=36, createdTime=2020-11-14, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfda20329e51, moduleTitle=EuroIntervention：接受COMBO支架治疗的ACS患者，3个月vs12个月的DAPT结局——REDUCE试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfda20329e51)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279353, encodeId=180812e935331, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=LDL-C<1.4 mmol/L，且降幅要≥50%！中国医师协会ACS血脂管理临床路径专家共识, objectType=article, longId=202683, objectId=2a142026831d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a142026831d, replyNumber=0, likeNumber=38, createdTime=2020-11-01, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a142026831d, moduleTitle=LDL-C<1.4 mmol/L，且降幅要≥50%！中国医师协会ACS血脂管理临床路径专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a142026831d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279352, encodeId=dda512e935253, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=专家访谈:生命至上——PCSK9抑制剂值得被更多ACS患者使用, objectType=article, longId=201145, objectId=331b20114592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=331b20114592, replyNumber=0, likeNumber=39, createdTime=2020-09-26, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=331b20114592, moduleTitle=专家访谈:生命至上——PCSK9抑制剂值得被更多ACS患者使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=331b20114592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279351, encodeId=6bcf12e9351ec, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=ESC 2020:ACS患者LDL-C管理：低一些好一些，早一些好一些？！, objectType=article, longId=200806, objectId=e491200806c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e491200806c7, replyNumber=0, likeNumber=38, createdTime=2020-09-19, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e491200806c7, moduleTitle=ESC 2020:ACS患者LDL-C管理：低一些好一些，早一些好一些？！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e491200806c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279350, encodeId=975b12e935025, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=指南直通车|长期口服抗凝剂NSTE-ACS患者的抗血小板治疗, objectType=article, longId=200095, objectId=248e2000953f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=248e2000953f, replyNumber=0, likeNumber=23, createdTime=2020-09-02, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=248e2000953f, moduleTitle=指南直通车|长期口服抗凝剂NSTE-ACS患者的抗血小板治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=248e2000953f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279349, encodeId=7de012e934912, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=聚焦ACS血脂管理临床路径，明确ACS管理目标 ——《急性冠脉综合征患者血脂管理临床路径专家共识》重磅发布, objectType=article, longId=199891, objectId=6ec5199891d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ec5199891d8, replyNumber=0, likeNumber=32, createdTime=2020-08-26, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ec5199891d8, moduleTitle=聚焦ACS血脂管理临床路径，明确ACS管理目标 ——《急性冠脉综合征患者血脂管理临床路径专家共识》重磅发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ec5199891d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279348, encodeId=d4bf12e934843, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=JAMA：替格瑞洛单药vs替格瑞洛+阿司匹林对ACS支架患者不良临床事件的影响, objectType=article, longId=196058, objectId=47b819605894, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47b819605894, replyNumber=0, likeNumber=38, createdTime=2020-06-19, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47b819605894, moduleTitle=JAMA：替格瑞洛单药vs替格瑞洛+阿司匹林对ACS支架患者不良临床事件的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47b819605894)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACS

2020-05-29

yaanren (审核中...)

前往app查看评论内容

#ACS#

Circulation：肌钙蛋白筛查ACS时，长期结果显示0/1小时策略不劣于0/3标准方案（RAPID-TnT研究）

2021-07-27

yaanren (审核中...)

前往app查看评论内容

#ACS#

Cardiovasc Diabetol：胰岛素治疗显著增加合并ACS的T2D患者的MACE复发风险！

2021-06-30

yaanren (审核中...)

前往app查看评论内容

#ACS#

J Med Chem: 双PROTAC来了：我国学者首次提出双重靶向降解（Dual PROTACs）药物设计新概念

2021-06-02

yaanren (审核中...)

前往app查看评论内容

#ACS#

ACS Biomater. Sci. Eng.：创新伤口新辅料，或将改善抗生素预防感染新格局

2021-05-14

yaanren (审核中...)

前往app查看评论内容

#ACS#

EHRA 2021｜《2021 EHRA 房颤患者NOACs应用实践指南》重磅发布！

2021-04-29

yaanren (审核中...)

前往app查看评论内容

#ACS#

全病程、多方位，数字化：“胸痛中心全流程管理——ACS脂控先锋”项目正式启动

2021-04-16

yaanren (审核中...)

前往app查看评论内容

#ACS#

轻松构建“智惠版”先进细胞分析平台！碧迪医疗正式发布FACSymphony TM A1流式细胞仪

2021-04-13

yaanren (审核中...)

前往app查看评论内容

#ACS#

综述：靶向蛋白降解(PROTACs)癌症治疗药物机制、以及新近进展、国内相关研发公司

2021-03-30

yaanren (审核中...)

前往app查看评论内容

#ACS#

JACC：采用双重抗血小板治疗的ACS患者或许不需停用氯吡格雷5天后才能进行冠脉搭桥术

2021-03-17

yaanren (审核中...)

前往app查看评论内容

#ACS#

J Am Coll Cardiol：大多ACS住院患者存在无明显出血的血红蛋白降低，且与一年死亡率相关

2021-03-07

yaanren (审核中...)

前往app查看评论内容

#ACS#

ACS Nano ：“撒泡尿照照”！AI诊断前列腺癌全新突破，只需20分钟，准确性近100%

2021-02-02

yaanren (审核中...)

前往app查看评论内容

#ACS#

急性冠脉综合征ACS合并上消化道出血的诊治

2020-12-02

yaanren (审核中...)

前往app查看评论内容

#ACS#

ACS Nano：复旦占昌友团队揭示天然IgG吸附，导致叶酸修饰纳米药物的失效

2020-11-16

yaanren (审核中...)

前往app查看评论内容

#ACS#

EuroIntervention：接受COMBO支架治疗的ACS患者，3个月vs12个月的DAPT结局——REDUCE试验结果

2020-11-14

yaanren (审核中...)

前往app查看评论内容

#ACS#

LDL-C<1.4 mmol/L，且降幅要≥50%！中国医师协会ACS血脂管理临床路径专家共识

2020-11-01

yaanren (审核中...)

前往app查看评论内容

#ACS#

专家访谈:生命至上——PCSK9抑制剂值得被更多ACS患者使用

2020-09-26

yaanren (审核中...)

前往app查看评论内容

#ACS#

ESC 2020:ACS患者LDL-C管理：低一些好一些，早一些好一些？！

2020-09-19

yaanren (审核中...)

前往app查看评论内容

#ACS#

指南直通车|长期口服抗凝剂NSTE-ACS患者的抗血小板治疗

2020-09-02

yaanren (审核中...)

前往app查看评论内容

#ACS#

聚焦ACS血脂管理临床路径，明确ACS管理目标 ——《急性冠脉综合征患者血脂管理临床路径专家共识》重磅发布

2020-08-26

yaanren (审核中...)

前往app查看评论内容

#ACS#

JAMA：替格瑞洛单药vs替格瑞洛+阿司匹林对ACS支架患者不良临床事件的影响

2020-06-19

科室
- - 订阅+
  - 更多科室
工具
服务